Data as of 2:10pm ET
| +0.08 / +1.32%|
The 3 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 12.00 and a low estimate of 7.00. The median estimate represents a +29.87% increase from the last price of 6.16.
The current consensus among 3 polled investment analysts is to Hold stock in Sucampo Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.